Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

← Back to all medicines

Carbocisteine 250 mg/ 5 ml syrup

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Carbocisteine may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Carbocisteine

Source: electronic medicines compendium (emc)
Official leaflet: Read the PIL on emc

What it is and what it is used for

for Carbocisteine 250 mg/5 ml syrup (called Carbocisteine in this leaflet) contains a medicine called carbocisteine. This belongs to a group of medicines called "mucolytics' used in the antibacterial treatment of respiratory infections, in the presence of bronchial hypersecretion. It works by making the mucus (catarrh) less sticky. This makes the mucus easier to exit when coughing. Carbocisteine syrup is used for problems in the airways when there is too much mucus or when it is too sticky.

What you need to know before you take it

e Carbocisteine Do not take Carbocisteine:

  • if you have a gastroduodenal ulcer;
  • ifyou are allergic to carbocisteine or any of the other ingredients of this medicine (listed in section 6). Warnings and precautions Talk to your doctor or pharmacist before taking Carbocisteine:
  • Asthmatic patients and with a history of bronchospasm,
  • Severe respiratory insufficiency,
  • Debilitated patients. Due to the decrease of the cough reflex, there is risk of obstruction of the airway as a consequence of the increase of the quantity of secretions. The use of Carbocisteine implies a decrease of the mucus viscosity and its removal, either through the ciliary activity of the epithelium, either through the cough reflex, therefore an increase of the expectoration and cough should be expected. Do not associate this medicine with an antitussive. Mucolytics, as they have the ability to destroy the gastric mucosa barrier, should be used with caution in individuals susceptible to gastroduodenal ulcers. Children This medicine is not indicated in children aged less than 2 years. Other medicines and Carbocisteine Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. You should not take cough calming or secretion-drying medicines, because these have an effect contrary to that of carbocisteine. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Pregnancy:

It is not recommended to use in the pregnant woman, especially during the first 3 months of pregnancy, even though no teratogenic effects have been detected. Breastfeeding: It is not recommended to use during breastfeeding because there are no safety data, concerning the passage of carbocisteine into breast milk. Considering its low toxicity, ifthe mother is treated with this product, the potential risks for the child seem negligible. Driving and using machines No effects were seen on the ability to drive and use machines. Carbocisteine contains Sucrose For use in children This medicine contains 2.8 g of sucrose in each 5 ml paediatric dose. May be harmful to teeth. If you have been told by your doctor that you have intolerance to some sugars, contact your doctor before taking this medicinal product. For use in adults This medicine contains 8.4 g of sucrose in each 15 ml adult dose. This should be taken into account in patients with diabetes mellitus. Ifyou have been told by your doctor that you have intolerance to some sugars, contact your doctor before taking this medicinal product. Carbocisteine contains methyl parahydroxybenzoate. May cause allergic reactions (possibly delayed). 3. How to take Carbocisteine Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Using the measuring device (oral syringe with 5 ml capacity), measure the quantity that you will need whether you are an adult or a child, according to the general posology. The syringe for oral administration is graduated per 0.25 ml. One graduation, 0.25 ml corresponds to 12.5 mg of carbocisteine.

How to take it

the syringe:

Step 1: Check the measurements on the side of the syringe to see how much to fill it. Step 2: Push the syringe's plunger all the way down. Then put the tip of the syringe into the medicine bottle. Step 3: Slowly pull back on the plunger until the syringe fills to the appropriate mark. Make sure there are not any large air bubbles in the syringe. If there are, empty the syringe and try again. Step 4: Place the end of the syringe into the mouth against the cheek and carefully press the plunger down slowly to gently release the medicine. After use replace the bottle cap. Wash the syringe in warm water and allow to dry. Store out of the reach of children. Use in adults The usual dose for adults is 15 ml, 3 times daily. If your symptoms improve, your dose may be lowered to 10 ml, 3 times daily. Use in children and adolescents This medicine is not indicated in children aged less than 2 years. From 2 to 5 years old: 1.25 ml to 2.5 ml, 4 times daily. From 6 to 12 years old: 5 ml, 3 times daily in evenly spaced intervals. After using the syrup, close the bottle well. If you take more Carbocisteine than you should If upset stomach, nausea and vomiting occur, you should stop taking Carbocisteine and see the doctor. If you forget to take Carbocisteine If it is almost time to take the next dose, only take the next dose. If not, take the forgotten dose as soon as you remember. Do not take a double dose to make up for a forgotten dose. If you stop taking Carbocisteine Not applicable. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Uncommon: Digestive changes: nausea, vomiting and diarrhoea. Rare:

Hypersensitivity reactions, as hives and bronchospasm. Special attention in the asthmatic patients due to the risk of occurring bronchoconstriction (contraction of a muscle of the bronchial wall that leads to a reduction in the air passage). In these cases, the treatment should be stopped. Headache, muscle pain, dizziness, urinary incontinence, palpitations and breathlessness. Not known Allergic reactions, such as skin rash. Special attention in the patients with compromised thyroid function due to the risk of occurring hypothyroidism. Gastric discomfort, bronchorrhea (increased bronchial secretion).

Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard By reporting side effects you can help provide more information on the safety of this medicine.

How to store it

Carbocisteine Do not store above 25°C.

Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and bottle after "EXP." The expiry date refers to the last day of that month. Once the bottle is opened, Carbocisteine must be used within 3 months. If your syrup appears to be discoloured or shown any other signs of deterioration, take it back to your pharmacist who will advise you. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

Contents of the pack and other information

What Carbocisteine contains

  • The active substance is carbocisteine. Each 5 ml of Carbocisteine contains 250 mg of carbocisteine.
  • The other ingredients are: sucrose, caramel (E150), gooseberry flavour, sodium hydroxide (for pH-adjustment), methyl parahydroxybenzoate (E218) and purified water.

What Carbocisteine looks like and contents of the pack Carbocisteine is presented as a yellow- amber liquid with gooseberry flavour and a sweet taste. 200 ml or 300 ml bottles, of type Ill amber glass, with measuring device (oral syringe with 5 ml capacity).

Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder Amdeepcha Limited, 85 Yarmouth Road,

Manufacturer Laboratérios Basi – Industria Farmacéutica, S.A. Parque Industrial Manuel Lourengo Ferreira, Lotes 8, 15e 16 3450-232 Mortagua, Portugal

Blafield, Norwich,

Tel.: +351 231 920 250

Norfolk NR13 4LQ, United Kingdom

Fax: +351 231 921 055 E-mail: [email protected]

This leaflet was last revised in November

Marketing

2019

1/CS(IC)/05/1911/359.v2

Not all pack sizes may be marketed.

Frequently asked questions about Carbocisteine 250 mg/ 5 ml syrup

How do I take Carbocisteine 250 mg/ 5 ml syrup?

Carbocisteine 250 mg/ 5 ml syrup comes as oral solution containing 250mg / 5ml. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.

What is the active substance in Carbocisteine 250 mg/ 5 ml syrup?

The active substance in Carbocisteine 250 mg/ 5 ml syrup is carbocisteine.

Are there equivalent medicines to Carbocisteine 250 mg/ 5 ml syrup?

Medicines with the same active substance, strength and form include: Carbocisteine 250 mg/5 ml Sugar Free Adult Syrup, Carbocisteine 250 mg/5 ml oral solution, Carbocisteine 250mg/5ml sugar-free oral solution. They are interchangeable only if your prescriber or pharmacist says so.

Where does this information come from?

This leaflet reproduces the patient information leaflet approved for Carbocisteine 250 mg/ 5 ml syrup, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.

Can I get Carbocisteine 250 mg/ 5 ml syrup without a prescription?

Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

Medicines with the same active substance: Carbocisteine (12 medicines)
See every medicine containing this substance, or browse the full A–Z of active substances.
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

Carbocisteine is a mucolytic agent for the adjunctive therapy of respiratory tract disorders characterised by excessive, viscous mucus, including chronic obstructive airways disease.

4.2. Posology and method of administration

Posology

Adults

Dosage is based upon an initial daily dosage of 2250 mg carbocisteine in divided doses, reducing to 1500 mg daily in divided doses when a satisfactory response is obtained e.g. for normal syrup 15 ml 3 times a day reducing to 10 ml 3 times a day.

Paediatric population

2 - 5 years: 1.25 - 2.5ml, four times a day.

6 - 12 years: 5 ml, three times a day.

Carbocisteine is contraindicated in children aged less than 2 years.

Method of administration

Use the measuring device to measure the appropriate amount, whether its use is for an adult or a child. The syringe for oral administration is graduated per 0.25ml. One graduation, 0.25ml corresponds to 12.5mg of carbocisteine.

How to use the syringe:

Step 1: Check the measurements on the side of the syringe to see how much to fill it.

Step 2: Push the syringe's plunger all the way down. Then put the tip of the syringe into the medicine bottle.

Step 3: Slowly pull back on the plunger until the syringe fills to the appropriate mark.

Make sure there are not any large air bubbles in the syringe. If there are, empty the syringe and try again.

Step 4: Place the end of the syringe into the mouth against the cheek and carefully press the plunger down slowly to gently release the medicine. After use replace the bottle cap. Wash the syringe in warm water and allow to dry. Store out of the reach of children.

4.3. Contraindications

Use in children less than 2 years of age.

Use in patients with active peptic ulceration.

Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

4.4. Special warnings and precautions for use

Special precautions:

- Asthmatic patients with a history of bronchospasm;

- Severe respiratory failure;

- Debilitated patients. By decreasing the cough reflex there is a risk of obstruction of the airways as a consequence of the secretions amount increase.

The use of Carbocisteine implies a decrease in the mucus viscosity and removal, either through the ciliary activity of the epithelium, or by the cough reflex. Therefore it is expected an increase of cough and sputum. This association of this medicine with antitussive medication is not recommended.

Caution is advised in the administration of carbocisteine in individuals susceptible to gastroduodenal ulcers, as mucolytics have the capacity to destroy the gastric mucosal barrier.

This medicine contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.

This medicine contains methyl parahydroxybenzoate. May cause allergic reactions (possibly delayed).

4.5. Interaction with other medicinal products and other forms of interaction

No drug interactions have been identified

4.6. Fertility, pregnancy and lactation

Pregnancy

Although tests in mammalian species have revealed no teratogenic effects, is not recommended during the first trimester of pregnancy.

Breast-feeding

It is unknown whether carbocisteine/metabolites are excreted in human milk.

Fertility

There is no known relevant data available on the effects of carbocisteine on fertility.

4.7. Effects on ability to drive and use machines

Carbocisteine has no or negligible influence on the ability to drive and use machines.

4.8. Undesirable effects

Adverse reactions listed by System Organ Class. Frequencies are defined using the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1000 to ≤1/100); rare (≥1/10,000 to ≤1/1,000); very rare (≤1/10,000); not known (cannot be estimated from the available data).

System Organ Class

Frequency

Adverse reaction

Cardiac disorders

Rare

Palpitations

Endocrine Disorders

Not known

Hypothyroidism.*

Gastrointestinal disorders

Uncommon

Nausea, vomiting and diarrhea.

Very rare

Gastrointestinal bleeding.

Not known

Gastric discomfort.

Immune system disorders

Rare

Urticaria and bronchospasm.**

Very rare

Rash.

Musculoskeletal and connective tissue disorders

Rare

Muscle pain

Nervous system disorders

Rare

Headache, dizziness, urinary incontinence, palpitations.

Respiratory, thoracic and mediastinal disorders

Rare

Shortness of breath.

Not known

Bronchorrhea.

Skin and subcutaneous tissue disorders

Not known

Stevens-Johnsons syndrome, erythema multiforme.

* Special attention in patients with compromised thyroid function due to the risk of transient hypothyroidism occurrence.

** Special attention in asthmatic patients due to the risk of bronchoconstriction occurrence (contraction of a muscle of the bronchial wall that leads to a reduction in airflow). In these cases, treatment discontinuation is recommended.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

4.9. Overdose

Gastrointestinal disturbance (gastralgias, nausea and vomiting) are the most likely symptoms of Carbocisteine overdosage.

💬 Ask about this leaflet

Ask anything about Carbocisteine 250 mg/ 5 ml syrup. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →